FDA OKs Cell Therapy to Lower Infection Risk After Stem Cell Transplant
Por um escritor misterioso
Descrição
Omidubicel reduced infections in blood cancer patients from 60% to 39% at 100 days posttransplant
Oncology/Hematology Hematologyarticles page [3]
Despite Progress, Government Can Better Protect Patients From
Severe Asthma Management: Addressing Emerging Evidence
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer
What are the differences between platelet rich plasma and stem
FDA Approves First CRISPR/Cas9 Gene-Editing Therapy
Advances and applications of induced pluripotent stem cells
A New Approach to Treat Childhood Leukemia: Novartis' CAR-T
Reprogramming stem cells in regenerative medicine - Mao - 2022
Although Promising, CAR T-Cell Therapy in T-ALL Carries Many
Perspective Chapter: Liposome Mediated Delivery of
Transplantation Transplantationarticles page [1]
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed
New research on CRISPR gene-editing in stem cells, infographic
de
por adulto (o preço varia de acordo com o tamanho do grupo)